NL-OMON55019已完成不适用
A Prospective, Concurrent Controlled, Open-Label, Multicenter Clinical Study to Assess the Long-Term Safety of the PRESERFLO® MicroShunt in Subjects with Primary Open-Angle Glaucoma Who Have Completed Participation in the INN-005 Randomized Controlled Study. - Long-Term Safety of the PRESERFLO® MicroShunt
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1.Subject has completed their Month 24 Follow-Up Visit in the INN-005 clinical
- •study conducted under IDE G130028. 2. Subject was randomized into the INN-005
- •study and received the PRESERFLO® MicroShunt deviceor trabeculectomy. (Subjects
- •who have had the device explanted, or replaced with another device, may be
- •included). 3. Subject is willing and able to comply with all study
- •requirements, including signing an informed consent form.
排除标准
- •1. Subject has exceeded the timeframe for the Month 60 Follow-Up Visit prior to
- •enrollment for participation in this long-term follow-up study.
研究者
相似试验
尚未招募
2 期
Study of the treatment of psoriasis by unani medicineCTRI/2020/03/023697ational Research Institute of Unani Medicine for Skin Disorders
已完成
3 期
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine.CTRI/2010/091/000071GlaxoSmithKline500
进行中（未招募）
1 期
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes MellitusMedDRA version: 12.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusType 2 Diabetes MellitusEUCTR2009-015386-30-GBSmithKline Beecham Corporation (doing business as GlaxoSmithKline)
进行中（未招募）
不适用
A research study comparing the long term safety (48 weeks) of the investigational drug SUN101 (glycopyrrolate) given by a nebulizer, with tiotropium bromide inhalation powder (Spiriva®) in patients with Chronic Obstructive Pulmonary Disease (COPD).MedDRA version: 17.1Level: PTClassification code 10009033Term: Chronic obstructive pulmonary diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-002696-18-CZSunovion Respiratory Development Inc.1,050
进行中（未招募）
1 期
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes MellitusMedDRA version: 12.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusType 2 Diabetes MellitusEUCTR2009-015386-30-FRSmithKline Beecham Corporation (doing business as GlaxoSmithKline)